Insider Transactions by Scott Kathleen D.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SPRYARS Pharmaceuticals, Inc.Scott Kathleen D.Chief Financial OfficerNov 29, 2022Buy$6.248,25051,5068,250Dec 01, 2022, 04:31 PM